⌘K
Loading ticker…
Marker Therapeutics, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Marker Therapeutics, Inc. Common Stock (MRKR) has a 3-month relative strength percentile of 35 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.2%, relative volume 1.11×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
35 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
MRKR is in a stage 3 topping pattern, week 1. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -8.9% / -2.8%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
MRKR is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $340K notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $340K |
| VXFVanguard Extended Market ETF | 0.00% | $166K |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MRKR Jan avg: -10.95% median: -5.17% win: 50% σ: 22.48% n: 4 2022-04-12 → 2026-05-29 | MRKR Feb avg: -17.15% median: -19.31% win: 0% σ: 6.91% n: 4 2022-04-12 → 2026-05-29 | MRKR Mar avg: -20.15% median: -15.88% win: 25% σ: 35.48% n: 4 2022-04-12 → 2026-05-29 | MRKR Apr avg: 2.92% median: -3.25% win: 40% σ: 11.69% n: 5 2022-04-12 → 2026-05-29 | MRKR May avg: 26.96% median: 7.53% win: 60% σ: 49.93% n: 5 2022-04-12 → 2026-05-29 | MRKR Jun avg: 30.45% median: 24.79% win: 75% σ: 34.18% n: 4 2022-04-12 → 2026-05-29 (current) | MRKR Jul avg: 10.28% median: -5.92% win: 25% σ: 35.20% n: 4 2022-04-12 → 2026-05-29 | MRKR Aug avg: -12.90% median: -14.50% win: 25% σ: 20.84% n: 4 2022-04-12 → 2026-05-29 | MRKR Sep avg: -6.43% median: -11.40% win: 25% σ: 18.76% n: 4 2022-04-12 → 2026-05-29 | MRKR Oct avg: 6.86% median: 15.48% win: 75% σ: 38.57% n: 4 2022-04-12 → 2026-05-29 | MRKR Nov avg: -1.36% median: 0.71% win: 50% σ: 26.48% n: 4 2022-04-12 → 2026-05-29 | MRKR Dec avg: 24.23% median: 4.51% win: 50% σ: 52.18% n: 4 2022-04-12 → 2026-05-29 |